Daito Pharmaceutical Co.,Ltd.
4577.T · JPX
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | ¥2,149,000 | ¥2,207,000 | ¥2,379,000 | ¥3,241,000 |
| Short-Term Investments | ¥0 | ¥0 | ¥0 | ¥0 |
| Receivables | ¥12,032,000 | ¥20,254,000 | ¥16,456,000 | ¥18,435,000 |
| Inventory | ¥18,155,000 | ¥18,412,000 | ¥20,731,000 | ¥21,069,000 |
| Other Curr. Assets | ¥9,034,000 | ¥835,000 | ¥860,000 | ¥856,000 |
| Total Curr. Assets | ¥41,370,000 | ¥41,708,000 | ¥40,426,000 | ¥43,601,000 |
| Property Plant & Equip (Net) | ¥33,002,000 | ¥31,826,000 | ¥31,707,000 | ¥31,465,000 |
| Goodwill | ¥0 | ¥0 | ¥0 | ¥0 |
| Intangibles | ¥703,000 | ¥531,000 | ¥477,000 | ¥481,000 |
| Long-Term Investments | ¥2,168,000 | ¥2,091,000 | ¥1,974,000 | ¥4,084,000 |
| Tax Assets | ¥0 | ¥359,000 | ¥0 | ¥0 |
| Other NC Assets | ¥1,595,000 | ¥1,489,000 | ¥2,046,000 | ¥2,000 |
| Total NC Assets | ¥37,468,000 | ¥36,296,000 | ¥36,204,000 | ¥36,032,000 |
| Other Assets | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Assets | ¥78,838,000 | ¥78,004,000 | ¥76,630,000 | ¥79,633,000 |
| Liabilities | – | – | – | – |
| Payables | ¥7,778,000 | ¥8,266,000 | ¥7,821,000 | ¥9,045,000 |
| Short-Term Debt | ¥2,999,000 | ¥3,457,000 | ¥3,199,000 | ¥3,299,000 |
| Tax Payable | ¥0 | ¥0 | ¥0 | ¥0 |
| Deferred Revenue | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Curr. Liab. | ¥6,084,000 | ¥4,851,000 | ¥3,717,000 | ¥5,093,000 |
| Total Curr. Liab. | ¥17,709,000 | ¥17,049,000 | ¥15,195,000 | ¥17,437,000 |
| LT Debt | ¥5,844,000 | ¥6,569,000 | ¥7,294,000 | ¥8,019,000 |
| Deferred Rev, NC | ¥0 | ¥0 | ¥0 | ¥0 |
| Deferred Tax Liab, NC | ¥0 | ¥30,000 | ¥0 | ¥0 |
| Other NC Liab. | ¥472,000 | ¥426,000 | ¥2,523,000 | ¥2,158,000 |
| Total NC Liab. | ¥8,917,000 | ¥8,884,000 | ¥9,817,000 | ¥10,177,000 |
| Other Liabilities | ¥0 | ¥0 | ¥0 | ¥0 |
| Cap. Leases | ¥3,095,000 | ¥0 | ¥0 | ¥0 |
| Total Liabilities | ¥26,626,000 | ¥25,933,000 | ¥25,012,000 | ¥27,614,000 |
| Equity | – | – | – | – |
| Pref Stock | ¥0 | ¥0 | ¥0 | ¥0 |
| Common Stock | ¥7,186,000 | ¥7,186,000 | ¥7,186,000 | ¥7,186,000 |
| Retained Earnings | ¥36,723,000 | ¥37,179,000 | ¥36,488,000 | ¥36,671,000 |
| AOCI | ¥1,312,000 | ¥1,314,000 | ¥1,212,000 | ¥1,209,000 |
| Other Equity | ¥0 | ¥1,000 | ¥1,000 | ¥0 |
| Total Equity | ¥52,170,000 | ¥52,003,000 | ¥51,530,000 | ¥52,012,000 |
| Supplemental Information | – | – | – | – |
| Minority Interest | ¥42,000 | ¥64,000 | ¥86,000 | ¥7,000 |
| Total Liab. & Tot. Equity | ¥78,838,000 | ¥78,004,000 | ¥76,628,000 | ¥79,633,000 |
| Net Debt | ¥6,694,000 | ¥7,819,000 | ¥8,114,000 | ¥8,077,000 |